Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer
Conditions: Metastatic Esophageal Squamous Cell Carcinoma Interventions: Drug: TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors (Sintilimab) Sponsors: Qingdao Central Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Hospitals | Research | Skin Cancer | Squamous Cell Carcinoma